WHO says anything short of full trial disclosure skews public spending
Drug, vaccine and medical device developers should publish all trial results according to the WHO, which says anything less skews R&D priorities and public healthcare investment.
Archives for April 13, 2015
AstraZeneca inks two research partnerships with PatientsLikeMe, Lead Discovery Center
With an eye on early-phase research, AstraZeneca has signed two deals – a five-year agreement to gain access to PatientsLikeMe’s network, and a three-year alliance with the Lead Discovery Center.
Abivax's ARV action could herald functional HIV cure, says firm
A drug candidate which prevents the export of viral RNA in infected cells could lead the way in developing a functional cure for HIV, according to Abivax.
Greenphire moves to new HQ and starts recruitment drive
Trial participant payment tech firm Greenphire has moved to a new Philadelphia headquarters to add capacity and plans to hire 40 more staff by the end of the year.
Quintiles, Parexel, PPD lead all CROs in US trial totals, review finds
CROs (contract research organizations) continue to collaborate with sponsors on more clinical trials in the US, though the largest companies, such as Quintiles, Parexel and PPD, are working on a much larger share of the research as collaborators than...
Parexel’s QSI acquisition: An opportunity for pharmacovigilance
With the closing of the acquisition of QSI (Quantum Solutions India), Parexel is looking to help serve its clients further in the pharmacovigilance space.